XML 18 R4.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses    
Research and development $ 8,542,000 $ 6,052,000
General and administrative 6,867,000 1,371,000
Total operating expenses 15,409,000 7,423,000
Loss from operations (15,409,000) (7,423,000)
Other income (expense)    
Interest income 1,591,000 126,000
Change in fair value of redeemable convertible preferred stock tranche liability 0 (1,526,000)
Total other income (expense) 1,591,000 (1,400,000)
Loss before income tax (13,818,000) (8,823,000)
Income tax provision 0 0
Net loss (13,818,000) (8,823,000)
Comprehensive loss $ (13,818,000) $ (8,823,000)
Net loss per share    
Weighted average common stock outstanding, basic (in shares) 19,927,848 2,229,637
Weighted average common stock outstanding, diluted (in shares) 19,927,848 2,229,637
Net loss per share, basic (in dollars per share) $ (0.69) $ (3.96)
Net loss per share, diluted (in dollars per share) $ (0.69) $ (3.96)